Benzinga's Microcap Movers for Monday April 16, 2012

Below are highlights from Benzinga's daily coverage of microcap securities making big moves:

Shares of Endocyte

, the West Lafayette, IN biopharmaceutical company, rose 100% Monday on 10 times the average daily volume. Merck

and Endocyte

announced Monday that they have entered into an agreement to develop and commercialize Endocyte's novel investigational therapeutic candidate vintafolide. Vintafolide is currently being evaluated in a Phase III clinical trial for platinum-resistant ovarian cancer, and a Phase II trial for non-small cell lung cancer; both studies are also using Endocyte's investigational companion diagnostic agent, etarfolatide. Endocyte closed at $7.62 on Monday.

Shares of Hauppauge Digital

, the Hauppauge, NY manufacturer of analog and digital TV tuner products for the personal computer, rose 37% Monday on 17 times the average daily volume. Hauppauge Digital announced Monday that Broadway, Hauppauge's live TV streamer for the iPad and iPhone, now has TV recording support. With this new feature, Broadway can record TV programs locally and then stream it to an iPad or iPhone at a later time. "Broadway" is a stand alone "box" which allows live TV to be watched on an Apple device in the home through a Wi-Fi connection, or anywhere in the world via an Internet connection. Broadway has a built-in over the air digital TV tuner, plus supports clear QAM digital cable TV and connections to cable or satellite set top boxes. Once connected to a TV source, Broadway can tune to a TV program and then either stream the live TV program to an iPad or iPhone, or, with the new feature, record the TV program to a locally attached storage device and then stream the recording at a later time. Hauppauge Digital closed at $1.36 on Monday.

Shares of Vringo

, the New York City provider of software products for mobile video entertainment, personalization, and mobile social applications, rose 30% Monday on 8 times the average daily volume. It was disclosed Friday that Mark Cuban had taken a 7.4% stake in Vringo. Vringo closed at $3.97 on Monday.